Impact of Saroglitazar as an Add-on Therapy to Rosuvastatin in Patients with Diabetic Dyslipidemia– A Prospective, Single Centre, Observational Study in Indian Patients
Harmanpreet Singh, Gurpreet Sethi & Kunal Jhaveri · Journal of Advances in Medicine and Medical Research · 2023
Background: Diabetic dyslipidemia in type 2 diabetes mellitus is defined by elevated TG levels and decreased HDL-C levels, as well as elevated or normal LDL-C levels. In diabetic dyslipidemia, the addition of saroglitazar to statins may provide comprehensive control of lipid para...
Open access
Research Article
10.9734/jammr/2023/v35i235312